Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,040,243
+$8,255,366 QoQ
Shares Held
317,411
+11.4% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#75
of 477 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2023CallValue
$1,252,350
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,624,947 across 342 Biotechnology names. CYTK ranks #46 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in CYTK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,040,243 | 317,411 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,784,877 | 285,008 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,411,040 | 274,017 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $1,774,629 | 44,156 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,288,683 | 91,171 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,670,817 | 258,917 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,174,948 | 58,600 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,983,537 | 85,345 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,252,350 | 15,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $7,667,721 | 91,840 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,847,691 | 96,663 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,389,612 | 42,600 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,568,770 | 215,083 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,039,623 | 175,461 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,092,595 | 22,551 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $3,214,433 | 87,325 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $26,834,814 | 588,741 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $24,252,234 | 678,574 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,118,708 | 410,243 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,704,960 | 546,215 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,519,491 | 121,246 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,463,802 | 668,074 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $10,342,233 | 438,788 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,386,964 | 372,092 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||